locked nucleic acid therapeutics (Cureon)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namelocked nucleic acid therapeutics (Cureon)

Drug Alias Nameanti-IgE LNA (Cureon)anti-delta opioid LNA (Cureon)locked nucleic acid therapeutics (Cureon)anti-PKC LNA (Cureon)anti-dopamine D2 LNA (Cureon) +[16]

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionImmunoglobulin E inhibitorsRNA polymerase II inhibitorsAntisense oligonucleotide inhibitors +[7]

TargetsRNA polymerase IIImmunoglobulin EDopamine D2 receptor +[5]

Therapy Area/IndicationsNerve DegenerationHypersensitivityNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesExiqon A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesExiqon A/S Cureon A/S

Active IndicationsN/A

Inactive IndicationsNerve DegenerationHypersensitivityNeoplasms

Other Information

ATC CodeN/A